Skip to content
Newsletter
Toggle navigation
Newsletter
Search for:
Search
About angioedema
Toggle menu
What is angioedema?
Types
Acquired angioedema
Hereditary angioedema
Idiopathic angioedema
Acute allergic angioedema
Drug-induced nonallergic angioedema
Causes
Diagnosis
Symptoms
Living with angioedema
Diet
Treatments
Toggle menu
Approved treatments
Experimental treatments
Featured topics
Toggle menu
Taking action with HAE
HAE and advocacy
Next steps after an HAE diagnosis
Beyond swelling: Other HAE symptoms
Treatment and management of HAE attacks
Raising a child with HAE
HAE triggers and prevention plan
HAE and preventive treatment
Bracing for a diagnosis
HAE and stress
Angioedema and skin care
View all
Navigating HAE
Videos: Mastering the science
Tattoos and HAE
HAE service dog
HAE pool prep
HAE journey
HAE genetics
HAE and factor XII
Managing HAE medications
HAE and women
Traveling with HAE
View all
News
Columns
Toggle menu
Dancing with Rare Disease
— Natalie Sirota
From the Caregiver’s HAErt
— Danita LaShelle Jones
Living Rare, Speaking Loud
— Hollie Amadio
Search
Close drawer
What can we help you find today?
Search for:
Search
Search
Anna Schoenbach, —
Articles by Anna Schoenbach
Recent Posts
Biocryst to acquire Astria, getting experimental navenibart for HAE
Where HAE and perimenopause meet, hormonal help is off limits
Ekterly eases most HAE attacks within 20 minutes, trial data show
Every HAE caregiver needs to ‘review the recipe’ before treatment
Phase 3 trial tests navenibart across 10 EU nations
Envelope icon
Subscribe to our newsletter
Get regular updates to your inbox.
LinkedIn
This field is for validation purposes and should be left unchanged.
Email Address
(Required)
Δ
